Napolitano, Natalie
Polikoff, Lee
Edwards, Lauren
Tarquinio, Keiko M.
Nett, Sholeen
Krawiec, Conrad
Kirby, Aileen
Salfity, Nina
Tellez, David
Krahn, Gordon
Breuer, Ryan
Parsons, Simon J.
Page-Goertz, Christopher
Shults, Justine
Nadkarni, Vinay
Nishisaki, Akira
,
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R18HS024511, R18HS024511, R18HS024511, R18HS024511)
Article History
Received: 24 September 2022
Accepted: 6 January 2023
First Online: 17 January 2023
Declarations
:
: All participating sites were members of the National Emergency Airway Registry for Children (NEAR4KIDS) collaborative and had the infrastructure to collect all TI safety process and outcome data. Each site’s Institutional Review Board granted approval or exempt status for the ongoing data collection with waiver of consent. The Children’s Hospital of Philadelphia served as the Data Coordinating Center (IRB 16–013147).
: Not Applicable.
: Mrs. Napolitano, Dr. Shults, Dr. Nadkarni, and Dr. Nishisaki received funding from AHRQ R18HS024511 for this work. Mrs. Napolitano had research and consulting relationships with Drager, Timpel, Philips/Respironics, Actuated Medical, and VERO-Biotech. Dr. Polikoff has a consulting relationship with Novavax. No other authors have conflicts of interest to declare.